Annual Research Progress of Glioma in China in 2022

Annual Research Progress of Glioma in China in 2022

Glioma, the most prevalent primary malignant tumor of the adult central nervous system, is highly malignant. Despite the current clinical treatment options including surgical resection, radiotherapy and chemotherapy, the survival period of patients is still relatively short, which poses a serious th...

Full description

Bibliographic Details
Main Authors: CHEN Wenlin, WANG Yuekun, LIU Qianshu, YE Liguo, ZHENG Zhiyao, ZHANG Xin, GONG Le, CAO Yaning, SONG Yixuan, GUO Xiaopeng, WANG Yu, MA Wenbin
Format: Article
Language:zho
Published: Editorial Office of Medical Journal of Peking Union Medical College Hospital 2023-09-01
Series:Xiehe Yixue Zazhi
Subjects:
glioma
gliomatosis cerebri
multimodal image
targeted therapy
immunotherapy
drug delivery systems
Online Access:https://xhyxzz.pumch.cn/en/article/doi/10.12290/xhyxzz.2023-0321

Internet

https://xhyxzz.pumch.cn/en/article/doi/10.12290/xhyxzz.2023-0321

Similar Items